BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 32406549)

  • 1. Platelets beyond their count, as a key element of the innate immune system in the fight against malaria.
    Lucchesi A
    Br J Haematol; 2020 Sep; 190(5):648-649. PubMed ID: 32406549
    [No Abstract]   [Full Text] [Related]  

  • 2. Mean platelet counts are relatively decreased with malaria but relatively increased with endemic Burkitt Lymphoma in Uganda, Tanzania, and Kenya.
    Peprah S; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Dhudha H; Mumia M; Ayers LW; Biggar RJ; Bhatia K; Goedert JJ; Mbulaiteye SM
    Br J Haematol; 2020 Sep; 190(5):772-782. PubMed ID: 32395868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against malaria and Epstein-Barr virus in childhood Burkitt lymphoma: a case-control study in Uganda.
    Carpenter LM; Newton R; Casabonne D; Ziegler J; Mbulaiteye S; Mbidde E; Wabinga H; Jaffe H; Beral V
    Int J Cancer; 2008 Mar; 122(6):1319-23. PubMed ID: 18000823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A preliminary report of epidemiological studies of Burkitt's lymphoma, Epstein-Barr virus infection and malaria in North Mara, Tanzania.
    Geser A; Brubaker G
    IARC Sci Publ; 1985; (60):205-15. PubMed ID: 2998990
    [No Abstract]   [Full Text] [Related]  

  • 5. Determination
    Thuku NW; Shikuku K; Mbugua A
    Pan Afr Med J; 2017; 27():226. PubMed ID: 28979628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of the voluntary agency hospital to cancer epidemiology.
    Burkitt DP; Williams EH; Eshleman L
    Br J Cancer; 1969 Jun; 23(2):269-74. PubMed ID: 5788034
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of platelet parameters and platelet membrane glycoproteins in childhood Burkitt lymphoma.
    Asare R; Opoku-Okrah C; Danquah KO; Opare-Sem O; Addai-Mensah O; Gyamfi D; Amponsah FA; Afriyie EY; Duneeh RV; Ofosu DN; Frimpong M
    Leuk Res; 2019 Sep; 84():106189. PubMed ID: 31326577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short communication: malaria and Burkitt's lymphoma in North Mara, Tanzania.
    Brubaker G
    IARC Sci Publ; 1984; (63):771. PubMed ID: 6536629
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathways to increased coverage: an analysis of time trends in contraceptive need and use among adolescents and young women in Kenya, Rwanda, Tanzania, and Uganda.
    Dennis ML; Radovich E; Wong KLM; Owolabi O; Cavallaro FL; Mbizvo MT; Binagwaho A; Waiswa P; Lynch CA; Benova L
    Reprod Health; 2017 Oct; 14(1):130. PubMed ID: 29041936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Some cancer patterns in Western Kenya and North West Tanzania.
    Burkitt DP; Bundschuh M; Dahlin K; Dahlin L; Neale R
    East Afr Med J; 1969 Apr; 46(4):188-93. PubMed ID: 5799662
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical trials in low-resource settings: the perspectives of caregivers of paediatric participants from Uganda, Tanzania and Kenya.
    van den Berg M; Ogutu B; Sewankambo NK; Merten S; Biller-Andorno N; Tanner M
    Trop Med Int Health; 2019 Aug; 24(8):1023-1030. PubMed ID: 31215122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kenya and Uganda grapple with Burkitt lymphoma.
    Wakabi W
    Lancet Oncol; 2008 Apr; 9(4):319. PubMed ID: 18380064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Prospective epidemiologic studies and the nature of the association between Epstein-Barr virus (EBV) and Burkitt's lymphoma (BL)].
    de-Thé G; Geser A
    C R Acad Hebd Seances Acad Sci D; 1976 Apr; 282(14):1387-90. PubMed ID: 181158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-malaria interaction models for Burkitt's lymphoma: implications for preventive trials.
    Morrow RH; Gutensohn N; Smith PG
    Cancer Res; 1976 Feb; 36(2 pt 2):667-9. PubMed ID: 175923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burkitt's lymphoma and malaria.
    Kafuko GW; Burkitt DP
    Int J Cancer; 1970 Jul; 6(1):1-9. PubMed ID: 4319231
    [No Abstract]   [Full Text] [Related]  

  • 16. Rituximab-associated changes in platelet count in patients with non-Hodgkin lymphoma.
    Wilop S; Galm O; Dada R; Osieka R; Jost E
    Leuk Lymphoma; 2008 Nov; 49(11):2116-24. PubMed ID: 19021054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Burkitt's tumour and holoendemic malaria in West Nile District, Uganda: malaria as a possible aetiologic factor.
    Kafuko GW; Baingana N; Knight EM; Tibemanya J
    East Afr Med J; 1969 Jul; 46(7):414-36. PubMed ID: 5354899
    [No Abstract]   [Full Text] [Related]  

  • 18. Is molecular biology the best alternative for diagnosis of malaria to microscopy? A comparison between microscopy, antigen detection and molecular tests in rural Kenya and urban Tanzania.
    Mens P; Spieker N; Omar S; Heijnen M; Schallig H; Kager PA
    Trop Med Int Health; 2007 Feb; 12(2):238-44. PubMed ID: 17300631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malaria in the Taveta area of Kenya and Tanganyika. Part II. Results after three and a half years' treatment of huts with dieldrin.
    SMITH A; DRAPER CC
    East Afr Med J; 1959 Dec; 36():629-43. PubMed ID: 13831857
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of a malaria suppression program on the incidence of African Burkitt's lymphoma.
    Geser A; Brubaker G; Draper CC
    Am J Epidemiol; 1989 Apr; 129(4):740-52. PubMed ID: 2923122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.